WhaleCreep
HomeFundsSabby Management, LLC › Q1 2026

Sabby Management, LLC 13F holdings, Q1 2026

Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →

Sabby Management, LLC disclosed 22 US equity positions worth $5.7m in its Q1 2026 13F filing. The largest position was SPY at 31.1% of the reported book, followed by ALPHATON CAPITAL CORP and BRIACELL THERAPEUTICS CORP.

· Q2 2026 →

What did Sabby Management, LLC own in Q1 2026? Top 22 positions

#StockSectorWeightValueSharesΔ sharesvs prior
1 SPY SPDR S&P 500 ETF 31.1%$1.8m2,734
2 ALPHATON CAPITAL CORP 11.5%$654.8k2,072,103
3 BRIACELL THERAPEUTICS CORP 6.9%$392.1k380,686
4 SNES SENESTECH INC 6.3%$358.4k218,533
5 BIG TREE CLOUD HLDGS LTD 5.9%$337.1k137,611
6 BRIACELL THERAPEUTICS CORP 5.4%$309.7k73,915
7 TOKEN CAT LTD 4.2%$241.7k23,239
8 POP CULTURE GROUP CO LTD 3.5%$201.1k664,449
9 MOLECULIN BIOTECH INC 3.0%$171.8k75,021
10 BIODEXA PHARMACEUTICALS PLC 2.8%$159.1k257,472
11 RKDA ARCADIA BIOSCIENCES INC 2.8%$158.1k114,554
12 TRX TRX GOLD CORP 2.6%$150.0k100,000
13 INM INMED PHARMACEUTICALS INC 2.5%$142.0k220,260
14 CAN FITE BIOFARMA LTD 2.3%$131.9k42,559
15 CHINA SXT PHARMACEUTICALS INC 2.3%$131.3k78,170
16 REVELATION BIOSCIENCES INC 2.1%$119.3k99,432
17 CALIDI BIOTHERAPEUTICS INC 1.8%$103.9k434,903
18 BLUEJAY DIAGNOSTICS INC 0.9%$52.9k28,726
19 LYRA THERAPEUTICS INC 0.9%$51.1k104,059
20 TEMPEST THERAPEUTICS INC 0.5%$29.3k17,856
21 BRIACELL THERAPEUTICS CORP 0.5%$28.9k206,753
22 BNB PLUS CORP 0.2%$8.7k13,541

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.